Last $10.98 USD
Change Today -0.03 / -0.27%
Volume 798.3K
NKTR On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Christopher A. Kuebler

Independent Director, Member of Nominating & Corporate Governance Committee and Member of Organization & Compensation Committee, Nektar Therapeutics
AgeTotal Calculated CompensationThis person is connected to 36 board members in 3 different organizations across 4 different industries.

See Board Relationships
60$368,930

Background*

Mr. Christopher A. Kuebler served as the Chief Executive Officer of Covance Inc. and its predecessor companies from November 1994 to January 1, 2005. Mr. Kuebler has 30 years of experience in the pharmaceutical and pharmaceutical service industries. He spent nearly 20 years in the pharmaceutical industry at Abbott Laboratories, Squibb Inc. and Monsanto Health Care. From November 1994 to November 2001, he was also President of Covance. From March 1993 to November 1994, ...

Read Full Background

Corporate Headquarters*

455 Mission Bay Boulevard South
San Francisco, California 94158

United States

Phone: 415-482-5300
Fax: 415-339-5300

Board Members Memberships*

1994-N/A
Former Director
2001-Present
Independent Director, Member of Nominating & Corporate Governance Committee and Member of Organization & Compensation Committee
2006-Present
Director and Member of Compensation Committee
2006-Present
Director and Member of Compensation Committee

Education*

BS
Florida State University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$67,750
Total Calculated Compensation$368,930
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NKTR:US $10.98 USD -0.03

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Peter M. Hecht Ph.D. Co-Founder, Chief Executive Officer and Director
Ironwood Pharmaceuticals, Inc.
$100.0K
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$590.6K
Peter William Grant Chief Executive Officer and Executive Director
SkyePharma plc
567.0K GBP
William J. Polvino M.D.Chief Executive Officer and President
Veloxis Pharmaceuticals A/S
--
Daniel J. Abdun-Nabi Chief Executive Officer, President, Director and Member of Strategic Operations Committee
Emergent BioSolutions, Inc.
$1.0M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEKTAR THERAPEUTICS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.